Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam · Delayed Price · Currency is VND 57,700
+100 (0.17%)
At close: Feb 9, 2026
HOSE:DCL Revenue
In the year 2025, Cuu Long Pharmaceutical JSC had annual revenue of 1.32T VND with 1.13% growth. Cuu Long Pharmaceutical JSC had revenue of 372.59B in the quarter ending December 31, 2025, a decrease of -26.98%.
Revenue
1.32T
Revenue Growth
+1.13%
P/S Ratio
3.19
Revenue / Employee
1.50B
Employees
880
Market Cap
4.21T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.32T | 14.79B | 1.13% |
| Dec 31, 2024 | 1.31T | 162.85B | 14.24% |
| Dec 31, 2023 | 1.14T | 128.26B | 12.63% |
| Dec 31, 2022 | 1.02T | 312.05B | 44.35% |
| Dec 31, 2021 | 703.63B | 32.39B | 4.83% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 4.98T |
| Traphaco JSC | 2.65T |
| Imexpharm | 2.44T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 950.89B |